You are listening to the DFJ Entrepreneurial Thought Leaders series, brought you weekly by the Stanford Technology Ventures Program.

You can find podcasts and videos of these lectures online at eChorner.standford.edu.

It is my distinct pleasure to welcome Sue Siegel here with us today.

She brings both corporate and venture capital background in growing organizations

and in also bringing new technologies to the forefront of biomedical research and health care.

Previously, she's been a general partner at Moore David Al here in town, and she has also

been president and director of Affimetics, where she grew that organization from an early stage

venture into a global leader in genomics and personalized medicine. Currently now, she is

CEO of GE's Healthy Imagination Unit and is working to kind of drive the innovations of that organization

to lower costs and improve access to better quality health on truly a global scale.

I'd like you to help me in welcoming Sue Siegel.

Thank you, Tom.

Well, good afternoon, and thanks for coming out on what was an incredibly stormy day. And I have to say, before I even get started, I want to thank Tina, Tom, Tom, and Matt

for inviting me here. And I have to tell you, over the last few semesters, Tina's actually tried

to get me out here. And we just couldn't ever find the Venn diagram overlap on the actual

opening in the series and the calendar. And finally, I do it. And so what happens? I make Tina

sick. So Tina's not here today. but I really do want to thank her for actually

inviting me. And I also want to say is, I've had a lot of colleagues that have come and

actually, you know, been with you, and they said they had a blast, just being able to present

and the sort of questions that they were asked. So I would like to tell them that I actually

had a blast too. So for that, I will say right now, in all honesty, it is an honor to be here.

I thank you guys for paying attention and actually for actively participating.

...